Price0.09%   +0.30
(After Hours: 325.00 +0.29 +0.09%)
Jun-07-22 03:25AM Lilly (LLY) Eczema Candidate Keeps Skin Clearance for One YearZacks Investment Research
09:36AM Company News for Jun 7, 2022Zacks Investment Research
Jun-05-22 10:30AM 2 Top Stocks to Buy With $500The Motley Fool
Jun-03-22 12:13PM LabCorp (LH) to Enhance Access to OmniSeq INSIGHT via New ProgramZacks Investment Research
06:00AM If You Invested $10,000 in Eli Lilly 10 Years Ago, This Is How Much You Would Have TodayThe Motley Fool
Jun-02-22 03:17AM Radius (RDUS) to Stop Work on Abaloparatide Transdermal SystemZacks Investment Research
11:31AM Pfizer (PFE) Up 5.5% Since Last Earnings Report: Can It Continue?Zacks Investment Research
Jun-02-22 10:59AM The Zacks Analyst Blog Highlights Eli Lilly, ConocoPhillips, PNC Financial Services, Equinix, and Freeport-McMoRanZacks Investment Research
06:20AM Is Invesco Dynamic Pharmaceuticals ETF (PJP) a Strong ETF Right Now?Zacks Investment Research
Jun-01-22 12:17PM Top Stock Reports for Eli Lilly, ConocoPhillips & PNC FinancialZacks Investment Research
10:53AM Got $5,000? Buy These 2 High-Growth Stocks Before They SoarThe Motley Fool
Jun-01-22 08:44AM Executives Sell Over $100M Of 4 StocksBenzinga
May-31-22 06:45AM Real Estate Trends for Investors to WatchThe Motley Fool
08:28AM Executives Sell Around $96M Of 5 StocksBenzinga
May-29-22 08:58AM A new generation of ulcerative colitis drugs is in development. Will they be blockbusters for Lilly and Pfizer?MarketWatch
07:31AM 3 Dividend Stocks You Can Buy and Hold ForeverThe Motley Fool
May-28-22 11:50AM A new generation of ulcerative colitis drugs is in development. Will they be blockbusters for Lilly and Pfizer?MarketWatch
May-27-22 10:37AM Is This Dividend Growth Stock a Buy?The Motley Fool
10:00AM 3 Reasons to Buy and Hold This Dividend StockThe Motley Fool
May-27-22 07:24AM A new generation of ulcerative colitis drugs is in development. Will they be blockbusters for Lilly and Pfizer?MarketWatch
May-26-22 02:40AM A new generation of ulcerative colitis drugs is in development. Will they be the blockbusters that pharma wants?MarketWatch
01:30AM Mizuho Sees Compelling Risk/Reward For This Schizophrenia Stock Despite Recent WeaknessBenzinga
May-25-22 08:10AM Executives Sell Around $207M Of 5 StocksBenzinga
05:38AM 3 Recession-Proof Stocks To Protect Your Portfolio From Fed-Induced TurmoilInvesting.com
May-24-22 10:53AM Why This FDA Approval Is a Game Changer for Eli LillyThe Motley Fool
09:39AM ImmunoGen (IMGN) Ovarian Cancer Drug BLA Gets Priority ReviewZacks Investment Research
May-23-22 02:44AM The Analyst Says 'Impressive Phase 3 Data Highlight Best-In-Class Opportunity' For Concert PharmaBenzinga
02:08AM What 7 Analyst Ratings Have To Say About Eli LillyBenzinga
May-23-22 11:33AM Lilly's (LLY) Olumiant Gets CHMP Nod for Alopecia AreataZacks Investment Research
10:33AM Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022Benzinga
May-20-22 04:17AM S&P 500 Falls For 7th Consecutive Week Amid Ongoing Inflation, Federal Reserve Rate Hike FearsBenzinga
12:54PM Radius (RDUS), Menarini Post Positive Data on Breast Cancer DrugZacks Investment Research
May-20-22 09:25AM Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck, and GlaxoZacks Investment Research
08:50AM Pharma Stock Roundup: FDA Nod to PFE COVID Jab for Age 5-11 & LLY's TirzepatideZacks Investment Research
May-20-22 08:03AM This Safe Stock Is Dirt Cheap -- and It's Beating the MarketThe Motley Fool
06:20AM Should First Trust Value Line Dividend ETF (FVD) Be on Your Investing Radar?Zacks Investment Research
May-19-22 09:32AM 4 Large Drug Stocks to Watch as the Industry RecoversZacks Investment Research
06:44AM PepsiCo And 3 Other Stocks Insiders Are SellingBenzinga
May-18-22 03:05AM AstraZeneca (AZN) Inks Deal to Develop COVID-19 AntibodiesZacks Investment Research
12:51PM The Correction In Biopharmaceutical Stocks Is Likely OverSeeking Alpha
May-16-22 02:20AM Why Eli Lilly Stock Climbed TodayThe Motley Fool
09:28AM Lilly's (LLY) Diabetes Treatment Tirzepatide Gets FDA NodZacks Investment Research
May-13-22 08:10AM Pharma Stock Roundup: PFE's Biohaven Buyout Offer, BAYRY's Q1 Earnings UpdateZacks Investment Research
May-12-22 10:53AM Got $10,000? These 3 Growth Stocks Also Pay DividendsThe Motley Fool
08:02AM Lilly's (LLY) Olumiant Gets Full Approval From FDA for COVIDZacks Investment Research
May-12-22 07:24AM WHO head censored in China after criticizing zero-COVID policy, and U.S. cases are now up 52% from two weeks agoMarketWatch
07:23AM How Novo Nordisk Will Protect Insulin SalesThe Motley Fool
May-11-22 12:54PM Why AbCellera Biologics Is 10% Lower TodayThe Motley Fool
10:21AM WHO head censored in China after criticizing zero-COVID policy, and U.S. cases up 52% from two weeks agoMarketWatch
May-11-22 06:20AM Should You Invest in the Invesco Dynamic Pharmaceuticals ETF (PJP)?Zacks Investment Research
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates through two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for the treatment of diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and pediatric growth conditions. The company also provides neuroscience products for the treatment of depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorder; obsessive-compulsive disorder, bulimia nervosa, and panic disorder; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains, as well as immunology products to treat Alzheimer's disease. In addition, it offers oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products to treat erectile dysfunction and benign prostatic hyperplasia; and migraine. Further, the company provides animal health products, such as cattle feed additives; protein supplements for cows; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; anticoccidial agents for poultry use; and chewable tablets that kill fleas and prevent heartworm diseases. Additionally, it offers vaccines to prevent bordetella, Lyme disease, rabies, and parvovirus. The company has collaboration agreements with Daiichi Sankyo Co., Ltd.; Incyte Corporation; Pfizer Inc.; AstraZeneca; Nektar Therapeutics; NextCure, Inc.; and Dicerna Pharmaceuticals, Inc., as well as has strategic collaboration with Sigilon Therapeutics. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Cap:    |  Volume (24h):